Shi et al. (7) presented data on the development and application of a PCR-based restriction fragment length polymorphism analysis of a 9.6-kb portion of the lipopolysaccharide gene (LG) cluster of Campylobacter jejuni and Campylobacter coli. This proposed molecular subtyping system is novel and has the potential of being directly applicable to epidemiology, prevalence, and other studies. I agree that if, as the authors contend, their proposed genotyping scheme has the same molecular basis as the Penner serotyping scheme (5, 6), then C. jejuni and C. coli isolates previously nontypeable by the Penner scheme are likely to be typeable by the LG scheme.
However, I do not agree that the proposed LG typing scheme is specific for C. jejuni and C. coli only. While C. lari and C. upsaliensis are less frequently isolated from clinical specimens than C. jejuni and C. coli, these organisms have been linked to colitis, bacteremia, spontaneous human abortion, the hemolytic-uremic syndrome, and other illnesses (1, 2, 3). C. lari strains are serotypeable by the Penner system (2, 8; A. J. Lastovica, unpublished data), as are C. upsaliensis strains (2; Lastovica, unpublished). That some strains of C. upsaliensis are serotypeable may reflect the genomic heterogeneity of C. upsaliensis, as has been proposed (4).
Since C. lari and C. upsaliensis are typeable with the Penner system, they also should be typeable by the LG scheme. This question was not adequately addressed, as only a single strain each of C. lari and C. upsaliensis was analyzed by the LG scheme and no PCR product was obtained (7).
Additional LG analysis on a number of serologically defined C. lari and C. upsaliensis strains will resolve this question and extend the usefulness of the proposed LG molecular subtyping scheme.
REFERENCES
- 1.Bourke, B., V. L. Chan, and P. Sherman. 1998. Campylobacter upsaliensis: waiting in the wings. Clin. Microbiol. Rev. 11:440-449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lastovica, A. J., E. Le Roux, and J. L. Penner. 1989. “Campylobacter upsaliensis” isolated from blood cultures of pediatric patients. J. Clin. Microbiol. 27:657-659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lastovica, A. J., and M. B. Skirrow. 2000. Clinical significance of Campylobacter and related species other than C. jejuni and C. coli, p 89-120. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter, 2nd ed. American Society for Microbiology, Washington, D.C.
- 4.Moser, I., B. Rieksneuwöhner, P. Lentzsch, P. Schwerk, and L. H. Wieler. 2001. Genomic heterogeneity and O-antigenic diversity of Campylobacter upsaliensis and Campylobacter helveticus strains isolated from dogs and cats in Germany. J. Clin. Microbiol. 39:2548-2557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Penner, J. L., and J. N. Hennessey. 1980. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J. Clin. Microbiol. 12:732-737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Penner, J. L., J. N. Hennessy, and R. V. Congi. 1983. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur. J. Clin. Microbiol. 2:378-383. [DOI] [PubMed] [Google Scholar]
- 7.Shi, F., Y. Y. Chen, T. M. Wassenaar, W. H. Woods, P. J. Coloe, and B. N. Fry. 2002. Development and application of a new scheme for typing Campylobacter jejuni and Campylobacter coli by PCR-based restriction fragment length polymorphism analysis. J. Clin. Microbiol. 40:1791-1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Woodward, D. L., and F. G. Rodgers. 2002. Identification of Campylobacter heat-stable and heat-labile antigens by combining the Penner and Lior serotyping schemes. J. Clin. Microbiol. 40:741-745. [DOI] [PMC free article] [PubMed] [Google Scholar]
